Results 171 to 180 of about 32,890 (266)

Risankizumab redefines Crohn's treatment after ustekinumab failure. [PDF]

World J Gastrointest Pharmacol Ther
Omullo FP.
europepmc   +1 more source

IgE to Galactose-α-1,3-Galactose (α-Gal) and Relevance to Ustekinumab First-Dose Infusion Reactions and Allergenicity. [PDF]

JGH Open
Venkat PG, Nehrbas JF, Bortz PS, Platts-Mills TA, Behm BW, Figueroa EJ, Wilson JM.   +6 more
europepmc   +1 more source

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg. [PDF]

J Crohns Colitis
De Greef E, Turner D, Kierkuś J, Korczowski B, Meglicka M, Cohen SA, Hyams JS, Griffiths AM, Rosh JR, Strauss R, Van Limbergen E, Adedokun OJ, Kim L, Volger S, UNITI Jr study Group.   +14 more
europepmc   +1 more source

Ustekinumab-associated morphoea: systematic review of the literature and a real-world case. [PDF]

Drugs Context
Sousa M, Alvarenga JM, Lé AM, Torres T.
europepmc   +1 more source

Biologic dose escalation in inflammatory bowel disease in the United States. [PDF]

J Manag Care Spec Pharm
Chapman C, Vadhariya A, Bires N, Brady BL, Creveling T, Ross R, Evans KA, Panni T, Chan-Diehl FW, McGinnis K.   +9 more
europepmc   +1 more source

Comparing Different As-Treated Approaches: A Methodological Study Using Real-World Data on Psoriasis Treatments. [PDF]

Pharmacoepidemiol Drug Saf
Kim S, Jensen A, Egeberg A, Stensballe LG.   +3 more
europepmc   +1 more source

Oral delivery of an ustekinumab biosimilar with bioavailability comparable to subcutaneous administration in healthy human participants. [PDF]

Eur J Clin Pharmacol
Myers JT, Yamaguchi A, Horlen K, Fung LC, Vo AT, Mohan D, Hoopes M, Imran M, Van Dam J, Gonen OM, Hashim MA, Dhalla AK, Blauvelt A.   +12 more
europepmc   +1 more source

Early proactive therapeutic drug monitoring with ustekinumab therapy in pediatric Crohn's disease: data from the prospective Canadian children IBD network. [PDF]

Crohns Colitis 360
Ricciuto A, McKay HE, deBruyn JC, Crowley E, Church PC, Huynh HQ, Otley AR, Shaikh A, Mack DR, Carman N, El-Matary W, Schneider R, Wine E, Walters TD, Griffiths AM, Canadian Children IBD Network .   +15 more
europepmc   +1 more source

The Unfolding of Familial CARD14- Associated Papulosquamous Eruption (CAPE) and a Brief Review. [PDF]

Indian Dermatol Online J
Shah S, Hegde SS, Inamadar A, Dahe NV.
europepmc   +1 more source

Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab. [PDF]

Biologics
Otake H, Matsumoto S, Mashima H.
europepmc   +1 more source